Archive
Home / Media Centre / Archive
Here you can find the archive of all Press Releases prior to 2022
Filter by date:
Showing 1107 press releases before 2022
-
AstraZeneca and Foundation Medicine enter strategic collaboration for Lynparza companion diagnostic assay
-
AstraZeneca completes US licensing agreement with Ironwood Pharmaceuticals for lesinurad
-
AstraZeneca licenses Zurampic to Grünenthal GmbH in Europe and Latin America
-
AstraZeneca’s Faslodex met primary endpoint in first-line treatment of advanced breast cancer
-
Positive CHMP opinion in EU for saxa/dapa (saxagliptin and dapagliflozin) for adults with type-2 diabetes
-
AstraZeneca receives Complete Response Letter from US FDA for sodium zirconium cyclosilicate (ZS-9) for oral suspension for treatment of hyperkalaemia
-
AstraZeneca highlights continued progress of oncology pipeline at 2016 ASCO Annual Meeting
-
AstraZeneca provides top-line results from Lynparza GOLD trial in advanced gastric cancer
-
AstraZeneca announces positive results from benralizumab phase III programme in severe asthma
-
Selumetinib granted Orphan Drug Designation in the US for adjuvant treatment of differentiated thyroid cancer
Latest articles and press releases
All of our latest press releases and articles are available to explore
